Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2)
Chime-Udeh, E.
Connecticut Medicine 55(9): 526-528
1991
ISSN/ISBN: 0010-6178 PMID: 1748007 Document Number: 377410
Document emailed within 1 workday
Related Documents
Sarfaty, G.A.; Alder, S.J.; McLean, R.G. 1984: A pilot study of flutamide. a new agent in the treatment of advanced prostatic cancer Medical Journal of Australia 140(4): 219-221Pummer, K. 1991: Epirubicin plus flutamide and orchidectomy in previously untreated advanced prostatic cancer Seminars in Oncology 18(5 Suppl 6: 26-28
Granados, E.A. 1998: Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery Archivos Espanoles de Urologia 51(7): 675-679
Neri, B.; Bartalucci, S.; Pieri, A.; Gemelli, M.T.; Rizzo, M.; Bartoletti, R.; Trippitelli, A.; Paoletti, M.C. 1989: Complete androgen blockade as treatment for advanced prostate cancer: clinical response and side-effects Anticancer Research 9(1): 13-16
Jackson, K.M.; Frazier, M.C.; Harris, W.B. 2007: Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer Anticancer Research 27(3b): 1483-1488
Rai, Y.; Sagara, Y.; Sagara, Y.; Takahama, T.; Matsuyama, Y.; Ando, M.; Sagara, Y.; Ooi, Y.; Inoue, K.; Kurosumi, M. 2007: Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(1): 65-68
Nagel, R. 1980: Practical limitations of a controlled multicenter therapeutic study with the example of advanced inoperable prostatic cancer Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 1304-1316
Teratani, T.; Shiina, S.; Obi, S.; Hamamura, K.; Koike, Y.; Akamatsu, M.; Fujishima, T.; Tateishi, R.; Imai, Y.; Shiratori, Y.; Omata, M. 2000: Percutaneous tumor ablation therapy for the advanced stage of HCC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(10): 1496-1500
Nishihara, C.; Kuratsukuri, K.; Tanaka, T.; Kawashima, H.; Nakatani, T. 2011: Successful combined treatment with maximal androgen blockade (MAB), intra arterial chemotherapy and radiation for advanced prostatic ductal adenocarcinoma : report of two cases Hinyokika Kiyo. Acta Urologica Japonica 57(4): 209-212
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258
Matzkin, H.; Braf, Z. 1994: Complete androgen blockage in the treatment of metastatic prostate cancer Harefuah 126(5): 260-263
Gómez Veiga, F.; Lorenzo Patiño, M.J.; Díaz Bermúdez, J.; Duarte Novo, J.; Alvarez Castelo, L.; Chantada Abal, V.; Sánchez Rodríguez, J.; González Martín, M. 1997: Effect of complete androgen block before radical prostatectomy for cancer of the prostate Archivos Espanoles de Urologia 50(4): 355-363
Sweeney, C.J. 2006: ECOG: CHAARTED--ChemoHormonal therapy versus androgen ablation randomized trial for extensive disease in prostate cancer Clinical Advances in Hematology and Oncology: H&o 4(8): 588-590
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Bosl, G.J.; Geller, N.L.; Chan, E.Y. 1988: Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors Cancer Research 48(12): 3524-3527
English, H.F.; Heitjan, D.F.; Lancaster, S.; Santen, R.J. 1991: Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer Cancer Research 51(7): 1760-1765
Duclos, J.; Cubillos, B.; Salgado, M.C.; Olea, C.; Casanova, D. 1991: Chronic dialysis in advanced age patients: a reasonable therapeutic alternative? Revista Medica de Chile 119(11): 1259-1263
Kazama, T.; Mizuno, I.; Takamine, T.; Umeda, K.; Terada, T.; Ishikawa, S.; Fuse, H.; Katayama, T. 1990: Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography Hinyokika Kiyo. Acta Urologica Japonica 36(12): 1423-1427
Magi-Galluzzi, C.; Xu, X.; Hlatky, L.; Hahnfeldt, P.; Kaplan, I.; Hsiao, P.; Chang, C.; Loda, M. 1997: Heterogeneity of androgen receptor content in advanced prostate cancer Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 10(8): 839-845
Granados Loarca, E.A.; Chéchile Toniolo, G.; Villavicencio Mavrich, H. 1996: LH-RH agonists as therapeutic alternative in patients with benign prostatic hyperplasia (BPH) and surgical contraindication. Long term follow up Archivos Espanoles de Urologia 49(9): 923-927